国务院任命曹雪涛任国家卫健委副主任

2022-09-02 网络 网络

人社部网站9月2日公布了国务院任免国家工作人员消息。其中,任命曹雪涛为国家卫生健康委员会副主任,免去曹雪涛的南开大学校长职务。

人社部网站9月2日公布了国务院任免国家工作人员消息。其中,任命曹雪涛为国家卫生健康委员会副主任,免去曹雪涛的南开大学校长职务。

目前,卫健委网站显示,曹雪涛已任国家卫生健康委员会副主任、党组成员。

此前,南开大学网站8月26日发布消息,日前,中央批准:曹雪涛不再担任南开大学校长、党委副书记职务,另有任用。 

图片

卫健委网站截图

曹雪涛,男,1964年7月出生,山东济南人,1985年1月加入中国共产党,1981年9月参加工作,研究生学历,医学博士,毕业于第二军医大学,中国工程院院士、德国科学院院士、美国国家医学科学院院士、美国人文与科学院院士、英国医学科学院院士。曾任第二军医大学免疫学教研室教师、副主任、主任,免疫学研究所所长、全军免疫与基因治疗重点实验室主任、医学免疫学国家重点实验室主任;2004年5月任第二军医大学副校长(2005年6月晋升专业技术少将);2010年8月任中国医学科学院北京协和医学院副院校长;2011年8月任中国医学科学院院长、北京协和医学院副校长;2015年11月任中国医学科学院北京协和医学院院校长;2017年12月任南开大学党委副书记、校长(副部长级);2022年8月任国家卫生健康委员会副主任、党组成员。

此外,曹雪涛还是中共十九大代表,第十二届、第十三届全国政协委员,教科卫体委员会副主任。

据中国工程院网站,曹雪涛创办《中国肿瘤生物治疗杂志》并任主编,Cellular and Molecular Immunology共同主编、Journal of Molecular Medicine、Cancer Immunology Research副主编, Cell、Annual Review of Immunology、Science Translational Medicine、Science Advances、eLife、Cell Research等编委。

学术方面,曹雪涛主要从事天然免疫与炎症的基础研究、肿瘤免疫治疗应用研究。以通讯作者在Cell、Nature、Science、Nature Immunology、Cancer Cell等发表SCI论文230余篇,引用1万余次。以第一完成人获国家自然科学二等奖1项 (2003)、中华医学科技奖一等奖2项、军队和上海市科技进步一等奖2项、上海市自然科学一等奖4项,获得国家发明专利16项,获得国家II类新药证书2个。获得中国工程院光华工程科技奖(2012)、中科院陈嘉庚生命科学奖(2016)、教育部长江学者成就奖、中国青年科学家奖等。培养的12名博士生获得全国优秀博士论文,获得首届中国研究生教育特等奖、Nature杰出导师终身成就奖。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1258948, encodeId=e2671258948b5, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291437, encodeId=3fcb129143ec1, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351484, encodeId=07c1135148453, content=<a href='/topic/show?id=c6e06030207' target=_blank style='color:#2F92EE;'>#曹雪涛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60302, encryptionId=c6e06030207, topicName=曹雪涛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242949, encodeId=64801242949a1, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:21:04 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242948, encodeId=5fce124294853, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:20:54 CST 2022, time=2022-09-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1258948, encodeId=e2671258948b5, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291437, encodeId=3fcb129143ec1, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351484, encodeId=07c1135148453, content=<a href='/topic/show?id=c6e06030207' target=_blank style='color:#2F92EE;'>#曹雪涛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60302, encryptionId=c6e06030207, topicName=曹雪涛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242949, encodeId=64801242949a1, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:21:04 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242948, encodeId=5fce124294853, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:20:54 CST 2022, time=2022-09-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1258948, encodeId=e2671258948b5, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291437, encodeId=3fcb129143ec1, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351484, encodeId=07c1135148453, content=<a href='/topic/show?id=c6e06030207' target=_blank style='color:#2F92EE;'>#曹雪涛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60302, encryptionId=c6e06030207, topicName=曹雪涛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242949, encodeId=64801242949a1, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:21:04 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242948, encodeId=5fce124294853, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:20:54 CST 2022, time=2022-09-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1258948, encodeId=e2671258948b5, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291437, encodeId=3fcb129143ec1, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351484, encodeId=07c1135148453, content=<a href='/topic/show?id=c6e06030207' target=_blank style='color:#2F92EE;'>#曹雪涛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60302, encryptionId=c6e06030207, topicName=曹雪涛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242949, encodeId=64801242949a1, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:21:04 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242948, encodeId=5fce124294853, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:20:54 CST 2022, time=2022-09-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1258948, encodeId=e2671258948b5, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291437, encodeId=3fcb129143ec1, content=<a href='/topic/show?id=e53140859f6' target=_blank style='color:#2F92EE;'>#国家卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40859, encryptionId=e53140859f6, topicName=国家卫健委)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351484, encodeId=07c1135148453, content=<a href='/topic/show?id=c6e06030207' target=_blank style='color:#2F92EE;'>#曹雪涛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60302, encryptionId=c6e06030207, topicName=曹雪涛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Sep 04 17:28:52 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242949, encodeId=64801242949a1, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:21:04 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242948, encodeId=5fce124294853, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0825417521, createdName=ms6000000960504356, createdTime=Sat Sep 03 12:20:54 CST 2022, time=2022-09-03, status=1, ipAttribution=)]
    2022-09-03 ms6000000960504356

    不错的文章

    0

相关资讯

国家重点研发计划公布 曹雪涛项目拿到近3千万

国家重点研发计划5个重点专项安排公示,曹雪涛负责项目获得了2863万的中央财政经费拨款。

Cell:重磅!曹雪涛团队发现晚期癌症恶化新机制

3月29日,《细胞》杂志发表了中国工程院院士、南开大学校长曹雪涛团队的研究论文,报道了在晚期癌症肿大的脾脏中发现了一种称之为Ter细胞的新型红细胞样亚群,此细胞能够通过分泌神经营养因子artemin而促进癌症恶性进展,该发现为癌症预后判断和干预治疗提出了新思路。

Cell:新型红细胞亚群促进肝细胞癌进展

中国工程院院士、南开大学校长曹雪涛团队在晚期癌症肿大的脾脏中发现了一种称之为Ter细胞的新型红细胞样亚群,此细胞能够通过分泌神经营养因子artemin而促进癌症恶性进展,该发现为癌症预后判断和干预治疗提出了新思路。这项新发现发表于最新的Cell杂志。

探秘:一个创新工程 为何让曹雪涛引以为豪?

发达国家对医疗很重视,体现在其独立的医学研究机构。而我国现状是各方投入存在交叉,但尚未形成合力。在新时期,应该建立新型的国家级医学研究管理体系。中国医学科学院 北京协和医学院院校长曹雪涛一席话针砭时弊,将我国医疗科学创新顽疾说通讲透,更将国家赋予中国医学科学院医学与健康科技创新工程(下称创新工程)的使命“昭告天下”。“创新工程的重要任务就是通过优化资源配置与配置优势资源,形成有助于科学创新的支

曹雪涛当选美国人文与科学院院士

4月18日,美国人文与科学院正式公布了2018年当选的院士名单,共有177位院士和36位外籍院士当选。其中,中国工程院院士、中国医学科学院原院长、南开大学校长曹雪涛和北京大学中文系资深教授、国学研究院院长袁行霈当选为该院外籍院士。据悉,美国人文与科学院于1780年5月4日由马萨诸塞州立法机构批准成立,是美国历史悠久的独立学术团体和政策研究中心。该院现有院士4900名,外籍院士600名,均是来自科学

两会声音:曹雪涛院士:大学评价要避免走入“唯排名论”误区,研究生体质健康要纳入考核指标

据中新社报道,全国政协委员、中国工程院院士、南开大学校长